Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 46.09 | 253.00 | 262.75 | 0.9629 | 0.9701 |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 190.00 | 262.75 | 0.7231 | 0.7578 | |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 317.00 | 262.75 | 1.2065 | 1.1552 | |
| MCF 10A | Erlotinib | 0.01 | uM | 9 | 156.25 | 46.09 | 158.00 | 262.75 | 0.6013 | 0.6333 |
| MCF 10A | Erlotinib | 3.1623 | uM | 9 | 156.25 | 46.09 | 61.00 | 262.75 | 0.2322 | 0.1181 |
| MCF 10A | 17-AAG | 0.31623 | uM | 9 | 156.25 | 46.09 | 34.00 | 262.75 | 0.1294 | -0.1141 |
| MCF 10A | Linsitinib | 19.9526 | uM | 9 | 156.25 | 46.09 | 40.00 | 262.75 | 0.1522 | -0.0549 |
| MCF 10A | Linsitinib | 0.01 | uM | 9 | 156.25 | 46.09 | 224.00 | 262.75 | 0.8525 | 0.8769 |
| MCF 10A | Linsitinib | 0.031623 | uM | 9 | 156.25 | 46.09 | 205.00 | 262.75 | 0.7802 | 0.8118 |
| MCF 10A | Lapatinib | 0.01 | uM | 9 | 156.25 | 46.09 | 231.00 | 262.75 | 0.8792 | 0.9000 |
| MCF 10A | 17-AAG | 0.031623 | uM | 9 | 156.25 | 46.09 | 39.00 | 262.75 | 0.1484 | -0.0644 |
| MCF 10A | Lapatinib | 0.1 | uM | 9 | 156.25 | 46.09 | 331.00 | 262.75 | 1.2598 | 1.1926 |
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 156.25 | 46.09 | 381.00 | 262.75 | 1.4500 | 1.3190 |
| MCF 10A | Linsitinib | 0.31623 | uM | 9 | 156.25 | 46.09 | 381.00 | 262.75 | 1.4500 | 1.3190 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 46.09 | 331.00 | 262.75 | 1.2598 | 1.1926 |
| MCF 10A | 17-AAG | 0.01 | uM | 9 | 156.25 | 46.09 | 85.00 | 262.75 | 0.3235 | 0.2760 |
| MCF 10A | Lapatinib | 0.031623 | uM | 9 | 156.25 | 46.09 | 283.00 | 262.75 | 1.0771 | 1.0600 |
| MCF 10A | Lapatinib | 0.0033113 | uM | 9 | 156.25 | 46.09 | 221.00 | 262.75 | 0.8411 | 0.8668 |
| MCF 10A | 17-AAG | 0.1 | uM | 9 | 156.25 | 46.09 | 28.00 | 262.75 | 0.1066 | -0.1800 |
| MCF 10A | Linsitinib | 0.0033113 | uM | 9 | 156.25 | 46.09 | 343.00 | 262.75 | 1.3054 | 1.2240 |
| MCF 10A | Linsitinib | 3.1623 | uM | 9 | 156.25 | 46.09 | 72.00 | 262.75 | 0.2740 | 0.1944 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 46.09 | 205.00 | 262.75 | 0.7802 | 0.8118 |
| MCF 10A | Lapatinib | 1 | uM | 9 | 156.25 | 46.09 | 139.00 | 262.75 | 0.5290 | 0.5521 |
| MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 234.00 | 262.75 | 0.8906 | 0.9098 | |
| MCF 10A | 0 | uM | 9 | 312.50 | 96.23 | 682.00 | 842.75 | 0.8093 | 0.8693 |